<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04264364</url>
  </required_header>
  <id_info>
    <org_study_id>ESGvsLSG</org_study_id>
    <nct_id>NCT04264364</nct_id>
  </id_info>
  <brief_title>ESG vs LSG: Short-term Nutritional Outcomes</brief_title>
  <official_title>Endoscopic Sleeve Gastroplasty in Comparison With Laparoscopic Sleeve Gastrectomy in Terms of Short-Term Nutritional Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Saud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Saud Medical City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King Saud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess endoscopic sleeve gastroplasty in comparison to laparoscopic sleeve gastrectomy
      before and 3 months after the procedure in terms of multiple nutrition-related factors,
      quality of life, weight and other related parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a short-term prospective cohort study, single-center study (NewYou clinical
      center - Riyadh). A total of 15 endoscopic sleeve gastroplasty patients will be matched with
      15 laparoscopic sleeve gastrectomy patients by age, gender and BMI. Total sample size is 30
      patients. Sample size was selected based on literature, considering the sample will be
      surgical patients and based on booked patients in the clinic. A multidisciplinary team will
      provide post-procedure care (including post-surgery diet stages protocol given by the
      center).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 16, 2019</start_date>
  <completion_date type="Actual">November 25, 2019</completion_date>
  <primary_completion_date type="Actual">November 25, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>3 months</time_frame>
    <description>Weight Loss in kilograms (baseline weight in kilogram - follow-up weight in kilogram)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of total weight loss (%TWL)</measure>
    <time_frame>3 months</time_frame>
    <description>%TWL = [(baseline weight in kilogram - weight at 3 months in kilogram) ÷ baseline weight in kilogram]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of excess weight loss (%EWL)</measure>
    <time_frame>3 months</time_frame>
    <description>%EWL = [percentage of weight lost compared with excess weight, which is defined as baseline weight in kilogram - the weight corresponding to a BMI of 25 kg/m^2 in kilogram])</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Waist Circumference</measure>
    <time_frame>3 months</time_frame>
    <description>Waist Circumference in centimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>body fat percentage change</measure>
    <time_frame>3 months</time_frame>
    <description>change in body fat percentage between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fat mass change</measure>
    <time_frame>3 months</time_frame>
    <description>change in fat mass in kilograms between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fat mass index change</measure>
    <time_frame>3 months</time_frame>
    <description>change in fat mass index in kg/m^2 between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fat free mass change</measure>
    <time_frame>3 months</time_frame>
    <description>change in fat free mass in kilograms between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fat free mass index change</measure>
    <time_frame>3 months</time_frame>
    <description>change in fat free mass index in kg/m^2 between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>skeletal muscle mass change</measure>
    <time_frame>3 months</time_frame>
    <description>change in skeletal muscle mass in kilograms between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dietary habits</measure>
    <time_frame>3 months</time_frame>
    <description>Assessment of dietary habits using the How Healthy Is Your Diet questionnaire, developed by the British Heart Foundation 2012
The score is from 0 minimum to 29. Higher score correlates with better dietary habits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24-hour dietary recall</measure>
    <time_frame>3 months</time_frame>
    <description>Assessment of nutritional intake with 24-hour dietary recall form</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3-day dietary record</measure>
    <time_frame>3 months</time_frame>
    <description>Assessment of nutritional intake with 3-day dietary record</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in quality of life after procedure</measure>
    <time_frame>3 months</time_frame>
    <description>Moorehead-Ardelt Quality of Life Questionnaire II scoring using Moorehead-Ardelt Quality of Life Questionnaire II Self Esteem and Activity Levels SCORING KEY minimum score is -3 and maximum score is 3 a higher score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cholesterol Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>Cholesterol in milligrams per deciliter (&lt; 200 Desirable)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alanine Aminotransferase Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>Alanine Aminotransferase in units per liter (up to 33)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gamma glutamyl transferase Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>Gamma glutamyl transferase in units per liter (&lt; 40)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sodium Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>sodium in millimoles/liter (136-145)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>platelets Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>platelets in cmm (150.0-450.0)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MCH Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>MCH in picograms per cell (25.00-32.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>potassium Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>potassium in millimoles/liter (3.5-5.1)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MCV Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>MCV in femtoliters per cell (76.00-97.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MCHC Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>MCHC in grams per deciliter (31.80-35.40)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chloride Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>Chloride in millimoles/liter (97-111)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>creatinine Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>creatinine in mg/dL (44-80)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WBC Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>WBC in × 10^9/L (4.00-11.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>RBC Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>RBC in million mcL (3.80-5.80)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HCT Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>HCT in % (36.00-46.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum glucose Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>serum glucose in mg/dL (70-150)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum TSH Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>serum TSH in milli-international units per liter (0.38-5.33)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hemoglobin Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>hemoglobin in grams per deciliter (12.00-16.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Eosinophils Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>Eosinophils in cells per microliter (0.00-6.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>monocytes Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>monocytes in percent (0.00-13.70)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>INR plasma ratio Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>INR plasma ratio (no units)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Basophils Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>Basophils in basophils per microliter (0.00-1.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MPV Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>MPV in fl (7.20-11.10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>RDW Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>RDW in % (12.40-16.20)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lymphocytes Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>lymphocytes in % (15.00-50.00)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophils Biochemical assessment (laboratory assessment)</measure>
    <time_frame>3 months</time_frame>
    <description>neutrophils in cells/µL (40.00-75.00)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Endoscopic Sleeve Gastroplasty</condition>
  <condition>Laparoscopic Sleeve Gastrectomy</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>laparoscopic sleeve gastrectomy</arm_group_label>
    <description>Patients who underwent laparoscopic sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endoscopic sleeve gastroplasty</arm_group_label>
    <description>Patients who underwent endoscopic sleeve gastroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic sleeve gastrectomy</intervention_name>
    <description>Bariatric surgical intervention</description>
    <arm_group_label>laparoscopic sleeve gastrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic sleeve gastroplasty</intervention_name>
    <description>Endoscopic bariatric procedure</description>
    <arm_group_label>endoscopic sleeve gastroplasty</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        27 LSG patients 30 ESG patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (≥ 18 years old)

          -  Willingness and ability to participate

          -  Males and females

          -  Non-pregnant

        Exclusion Criteria:

          -  Children (&lt;18 years old)

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ghadah M AlGhafees, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Saud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New You Medical Center</name>
      <address>
        <city>Riyadh</city>
        <zip>13326</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 30, 2020</study_first_submitted>
  <study_first_submitted_qc>February 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>February 9, 2020</last_update_submitted>
  <last_update_submitted_qc>February 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Saud University</investigator_affiliation>
    <investigator_full_name>Ghadah AlGhafees</investigator_full_name>
    <investigator_title>Clinical Nutrition Master's Student</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

